Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07260032 · ClinicalTrials.gov registry record · NA
Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
A NA study of PTSD and Cardiovascular Disease, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07260032: Recruiting NA study of PTSD and Cardiovascular Disease, sponsored by Massachusetts General Hospital.
NCT07260032 is a NA study of PTSD and Cardiovascular Disease that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 10 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07260032, a NA study of PTSD and Cardiovascular Disease, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use a non-invasive imaging technique called positron emission tomography/magnetic resonance imaging (PET/MRI) to investigate the effects of exercise on brain activity and arterial (blood vessel) inflammation in people with PTSD symptoms and evidence of or elevated risk for artery disease.
Primary Outcome
10-minute resting heart rate will be measured in beats per minute and collected from electrocardiogram (ECG)
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT07260032 shows while recruiting
NCT07260032 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT07260032 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07260032 about?
NCT07260032 is a clinical study titled "Determining the Benefits of Exercise on Cardiovascular Risk in PTSD". The purpose of this study is to use a non-invasive imaging technique called positron emission tomography/magnetic resonance imaging (PET/MRI) to investigate the effects of exercise on brain activity and arterial (blood vessel) inflammation in people with PTSD symptoms and evidence of or elevated ris...
What is the current status of trial NCT07260032?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-02-01. Estimated completion is 2027-01-31.
What conditions does trial NCT07260032 study?
This clinical trial studies the following conditions: PTSD, Cardiovascular Disease, Cardiovascular Disease Risk Factors.
What interventions are being tested in trial NCT07260032?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07260032?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07260032 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07260032's enrollment target sits among peer trials
10 150th of 154 higher than 3 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI